InformedDNA, a St. Petersburg, FL-based company that’s innovating the application of genomic insights, acquired gWell Health, a digital health, genomics, and wellness company.
The amount of the deal was not disclosed. As part of InformedDNA’s acquisition, gWell’s founder and CEO Surya Singh, MD, has transitioned to the role of InformedDNA Chief Executive Officer.
Dr. Singh brings more than 20 years of healthcare leadership experience to InformedDNA, spanning a diverse array of organizations. In addition to co-founding gWell and serving as its CEO, he previously served as corporate vice president and chief medical officer at CVS Health Specialty, chief medical officer of Emerging Therapy Solutions, chief medical officer and head of product at Proventys (acquired by McKesson Corporation) and as a healthcare strategy consultant at McKinsey & Company. Dr. Singh is also currently a senior advisor to the nonprofit Institute for Clinical and Economic Review (ICER). He is board-certified in internal medicine, previously practiced as an attending physician at the Brigham & Women’s Hospital, and has been a member of the teaching faculty at Harvard Medical School for 20 years.
InformedDNA’s deep genomic expertise partnered with gWell’s technology platform will accelerate the industry’s access to tech-enabled, genomic-guided decision-making to enhance patient care.
The gWell platform is designed to create a personalized wellness plan for users based on DNA analysis, health history, and lifestyle. Through the addition of gWell, InformedDNA bolsters its genomic offerings to meet the need for attainable genomics resources, offering technology and tools backed by decades of genetics expertise. InformedDNA’s existing clinical genetics experts will expand the existing gWell platform of proactive health management and patient experience tools utilized for musculoskeletal health to bring precision healthcare to oncology, drug metabolism, and maternity care. gWell’s solutions further strengthen InformedDNA’s ability to provide ongoing, dynamic genomic education and interaction across the care continuum.
FinSMEs
25/09/2023